ID,Project name,Dosage Form,Batch Number,Strength,Type of Container,Type of Closure,Desiccant,Cotton or Similar Material ,Stabilitiy Storage Conditions,Test Intervals Long Term ,Test Intervals Intermediate,Tesr Intervals Accelerated,Container Orientation,"Stability Specification Number, if applicable",Required Test per Interval & amount of samples,Total amount of samples per study including spares,Stability Checklist Completed by:,Stability Checklist Approved by Analytical Project Manager:,stability Checklist Approved by (QA): ,
,,,,,,,,,,,,,,,Test name,Conditions and Intervals,Amount (samples x time points,,Name & Signature,Date ,Name & Signature,Date ,Name & Signature,Date 
111,CLE-900,API,6556776,Null,HDP Bottle,Nitrogen,Yes ,No,Long Term ****,T-Zero,18M,1M,Horizontal ,73486348,djcjk,Null,30 tablets ,60,Mark ,20/04/2025,Diana ,20/04/2025,Menashe,20/04/2025
112,CLE-100,Tablets,67685658,5 mg,LDPE Bag,Head Seal ,No,Yes,Accelerated ****,18M,4M,3M,NA,7458340,gjkl,6 month,50 tablets ,100,Mark ,29/04/2025,Diana ,30/04/2025,Menashe,30/04/2025
113,CLE-300,Coated Tablets,749337,1 g,HDP Bottle,Nitrogen,NA,NA,Intermediate ****,2M,5M,33M,Upright ,949834893,drfgjj,1 month ,10 tablets ,30,Mark ,05/05/2025,Diana ,05/05/2025,Menashe,05/05/2025
114,CLE-301,Capsulot,484930,40 mg,LDPE Bag,Head Seal ,NA,Yes ,Accelerated ****,4M,T-Zero,T-Zero,Inverted,7478489,gfhytt,7 month,25 tablets ,50,Mark ,14/05/2025,Diana ,19/05/2025,Menashe,19/05/2025
115,CLE-101,Cream,954840,Null,HDP Bottle,Head Seal ,Yes ,No ,Intermediate ****,48M,1M,4M,Horizontal ,9484588,mnbvt,Null,60 tablets ,60,Mark ,25/05/2025,Diana ,27/05/2025,Menashe,27/05/2025
